InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Keeney Adam. Officer active across 1 company, notably BIOGEN INC.. In total, 6 filings have been recorded. Activity tracked since 1 May 2024. The latest transaction was filed on 1 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Keeney Adam is Head of Corporate Development at BIOGEN INC. He has 6 filings in total, and the sampled recent filings cover the period from 2024-05-03 to 2026-05-05. In those recent filings, both the buy and sell amounts are 0 EUR, and the most frequent transaction nature is option exercise.